Articles |
From the Institute of Pathology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio (J.D.E., D.W.L., G.L.M., P.S., J.B.L.), and the Oklahoma Medical Research Foundation, Oklahoma City (J.H.M.).
Abstract Increased platelet aggregation is associated with higher coronary artery disease mortality. Enhanced platelet aggregation in platelet-rich plasma has also been described in the elderly. To define age-related changes in primary hemostasis, we studied 37 elderly and 31 young blood donors. There were no significant age-related differences in whole-blood platelet aggregation, platelet adherence and thrombus formation on human umbilical artery segments, or bleeding time. Plasma fibrinogen was significantly higher in elderly men and women, whereas activated factor VII was elevated only in elderly women. Collagen-induced platelet aggregation was significantly correlated with platelet adherence to the subendothelium in elderly (r=.488, P=.002) but not in young donors. Accordingly, collagen-induced platelet aggregation showed a significant inverse correlation with bleeding time only in the elderly (r=-.401, P=.014). Arachidonic acidinduced platelet aggregation was significantly associated with platelet adherence to the subendothelium (r=.658, P=.003) and bleeding time (r=-.540, P=.021) only in elderly men. In young donors, ADP-induced platelet aggregation was significantly correlated with platelet adherence to the thrombogenic adventitial surface (r=.395, P=.031); in the elderly this association only approached significance (r=.315, P=.058). Whole-blood platelet aggregation in response to collagen and arachidonic acid may be more useful in predicting primary hemostatic function in the elderly than in the young. Furthermore, in the elderly, the correlation between platelet aggregation in whole blood and plateletarterial wall interactions in vitro and in vivo may contribute to the ability of this test to predict coronary risk.
Key Words: platelet adherence platelet aggregation aging fibrinogen factor VII
This article has been cited by other articles:
![]() |
C. Velik-Salchner, S. Maier, P. Innerhofer, W. Streif, A. Klingler, C. Kolbitsch, and D. Fries Point-of-Care Whole Blood Impedance Aggregometry Versus Classical Light Transmission Aggregometry for Detecting Aspirin and Clopidogrel: The Results of a Pilot Study Anesth. Analg., December 1, 2008; 107(6): 1798 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mascelli, S. Worley, N. J. Veriabo, E. T. Lance, S. Mack, T. Schaible, H. F. Weisman, and R. E. Jordan Rapid Assessment of Platelet Function With a Modified Whole-Blood Aggregometer in Percutaneous Transluminal Coronary Angioplasty Patients Receiving Anti-GP IIb/IIIa Therapy Circulation, December 2, 1997; 96(11): 3860 - 3866. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |